Reviewed by Dr. Ankeet Choxi
Summary: Dr. Mari Dezawa’s pioneering discovery of MUSE Cells has redefined stem cell science by identifying a rare population of stress-enduring, pluripotent-like adult cells. This article explores her background, scientific contributions, and the potential of MUSE Cells to support targeted regenerative therapy in joint and spine repair.
Who Is Dr. Mari Dezawa?
Dr. Mari Dezawa is a globally recognized stem cell researcher and the current Chief Scientific Officer of Muse Cell Innovations (MCI). A professor at Tohoku University in Japan, Dr. Dezawa has authored more than 200 peer-reviewed publications in the field of neuroscience, cell biology, and regenerative medicine.
Her most widely known achievement is the discovery of MUSE Cells (Multilineage-differentiating Stress-Enduring Cells) – a unique subset of adult mesenchymal stem cells (MSCs) that exhibit pluripotent-like properties without the risks typically associated with embryonic or induced pluripotent stem cells (iPSCs).
What Are MUSE Cells?
MUSE Cells are a rare population of cells – comprising only 1–2% of standard MSCs – that naturally exist in adult tissues, such as bone marrow and umbilical cord tissue. They are marked by the surface antigen SSEA-3+ and can withstand extreme cellular stress, which makes them especially promising in injury recovery and regenerative medicine applications.
Unlike iPSCs or embryonic stem cells, MUSE Cells are non-tumorigenic, ethically sourced, and do not require genetic manipulation. This makes them an attractive option for targeted regenerative therapy, particularly for orthopedic conditions involving the spine, joints, and soft tissues.
Scientific Properties and Stress Endurance
SSEA-3+ Cell Isolation and Identification
MUSE Cells are isolated based on the presence of SSEA-3 (Stage-Specific Embryonic Antigen-3) – a marker commonly associated with pluripotency. Dr. Dezawa’s team demonstrated that by subjecting MSC populations to cellular stress (such as prolonged suspension culture or exposure to cytotoxic environments), only MUSE Cells survived.
This ability to thrive under harsh conditions gave rise to the term “stress-enduring” stem cells and served as the foundation for their functional identification.
Pluripotent-Like Behavior Without Tumor Risk
MUSE Cells can differentiate into ectodermal, mesodermal, and endodermal lineages, showing broad therapeutic potential. Yet, unlike other pluripotent cells, they do not form teratomas – a critical safety advantage in clinical use.
This balance of plasticity and safety is what positions MUSE Cells as a next-generation regenerative tool, especially for complex tissue structures like cartilage, intervertebral discs, and tendons.
How MUSE Cells Work in Regenerative Medicine
Homing to Sites of Injury
One of the most important clinical features of MUSE Cells is their ability to home to areas of inflammation and tissue damage after local or systemic delivery. Once there, they participate in repair through:
- Differentiation into functional cell types (e.g., chondrocytes or nerve-supporting cells)
- Secretion of trophic factors that reduce inflammation
- Support of surrounding cell populations through paracrine signaling
These properties are currently being explored for conditions ranging from spinal degeneration to rotator cuff injuries, where long-term tissue support is needed.
Applications in Joint and Spine Repair
Dr. Dezawa’s work, now supported through partnerships like MCI and exclusive clinical providers such as STEMS Health in Florida, has focused increasingly on orthopedic repair. Key target areas include:
- Knee osteoarthritis and cartilage loss
- Degenerative disc disease and spine instability
- Tendon healing in the shoulder and hip
- Post-injury recovery without surgery
Unlike traditional MSC therapies, which may rely heavily on bulk cell counts and general anti-inflammatory effects, MUSE Cells function with precision, using both targeted tissue homing and cellular communication dynamics to accelerate healing.
Translating MUSE Cell Research to Clinical Care
Today, MUSE Cell therapy is entering real-world application through licensed clinics, including STEMS Health in Miami Beach, one of only a handful of Florida regenerative medicine providers authorized by MCI (Muse Innovations) to administer authentic Dezawa MUSE Cells.
Clinical protocols focus on localized orthopedic use, including guided injections into knees, shoulders, and spine-related structures. No IV therapies are currently promoted or offered.
Dr. Dezawa remains involved in ongoing research to support clinical translation of MUSE Cells through:
- Peer-reviewed studies in orthopedics, neurology, and immunology
- Expansion of GMP-compliant cell lines for therapy
- Partnerships with institutions and biotech firms to validate safety, dosing, and therapeutic outcomes
Her continued leadership ensures that MUSE Cells are developed responsibly and that they remain rooted in scientific integrity and clinically relevant use cases.
FAQs
What makes Dr. Dezawa’s discovery of MUSE Cells unique?
She identified a stress-resistant subset of adult MSCs with pluripotent-like behavior – able to differentiate and support tissue repair without the risks of iPSCs or embryonic stem cells.
Are MUSE Cells safer than traditional pluripotent stem cells?
Yes. Unlike iPSCs, MUSE Cells are non-tumorigenic and do not require reprogramming, offering a safer path to regenerative therapy.
Do MUSE Cells replace traditional MSCs?
No. MUSE Cells complement the field by offering more targeted and enduring regenerative properties. Traditional MSCs remain useful in many therapies.
Can MUSE Cells treat spine and joint conditions?
Yes. Current protocols support their use in treating orthopedic pain, degeneration, and soft tissue injuries in areas like the knee, shoulder, and spine.
Where can patients access MUSE Cell therapy?
STEMS Health is one of the few licensed clinics in Florida authorized to administer authentic Dezawa MUSE Cells, with a focus on orthopedic pain management.
Disclaimer
The information provided in this article is for educational and informational purposes only and is not intended as medical advice. Treatments and outcomes described may not be appropriate for every individual. Always consult a licensed healthcare provider to determine the best course of care for your specific needs.
Certain regenerative medicine procedures discussed – such as stem cell therapy, exosome therapy, or other biologic treatments – may be considered investigational or not FDA-approved for all conditions. Florida law requires that we disclose this status. While these procedures are offered in accordance with state and federal guidelines, their safety and efficacy have not been fully established by the U.S. Food and Drug Administration.
Results vary, and no guarantee of specific outcome or benefit is implied. All medical procedures involve potential risks, which should be discussed with your treating provider prior to treatment.
© STEMS Health Regenerative Medicine, Miami Beach, Florida. All rights reserved.
